$GLTO
Galecto, Inc.

2024 Q3 Form 10-Q Financial Statement

#000095017024095383 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.747M $2.775M
YoY Change -16.76% -9.61%
% of Gross Profit
Research & Development $1.093M $1.834M
YoY Change -57.15% -77.33%
% of Gross Profit
Depreciation & Amortization $6.000K $5.000K
YoY Change -97.16% -70.59%
% of Gross Profit
Operating Expenses $3.840M $5.577M
YoY Change -55.26% -50.02%
Operating Profit -$3.840M -$5.577M
YoY Change -55.26% -50.02%
Interest Expense -$36.00K $281.0K
YoY Change -108.0% -32.29%
% of Operating Profit
Other Income/Expense, Net -$36.00K $281.0K
YoY Change -108.05% -32.29%
Pretax Income -$3.876M -$5.296M
YoY Change -52.38% -50.71%
Income Tax $7.000K $42.00K
% Of Pretax Income
Net Earnings -$3.883M -$5.338M
YoY Change -52.27% -50.32%
Net Earnings / Revenue
Basic Earnings Per Share -$3.39 -$0.20
Diluted Earnings Per Share -$3.39 -$0.20
COMMON SHARES
Basic Shares Outstanding 27.13M 27.11M
Diluted Shares Outstanding 1.145M 27.12M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.68M $22.86M
YoY Change -55.48% -56.14%
Cash & Equivalents $19.68M $22.86M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $222.0K $464.0K
YoY Change 11.0% -5.88%
Inventory
Prepaid Expenses
Receivables $73.00K $121.0K
Other Receivables $1.205M $1.721M
Total Short-Term Assets $21.20M $25.20M
YoY Change -54.99% -54.48%
LONG-TERM ASSETS
Property, Plant & Equipment $62.00K $67.00K
YoY Change -50.4% -93.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.104M $1.986M
YoY Change -12.95% -19.92%
Total Long-Term Assets $2.176M $2.097M
YoY Change -26.21% -39.06%
TOTAL ASSETS
Total Short-Term Assets $21.20M $25.20M
Total Long-Term Assets $2.176M $2.097M
Total Assets $23.38M $27.30M
YoY Change -53.29% -53.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $503.0K $724.0K
YoY Change -88.76% -86.97%
Accrued Expenses $1.938M $2.985M
YoY Change -76.01% 36.3%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.400M $3.700M
YoY Change -80.95% -75.16%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.400M $3.700M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.441M $3.709M
YoY Change -80.73% -75.44%
SHAREHOLDERS EQUITY
Retained Earnings -$270.8M -$266.9M
YoY Change 8.49% 10.52%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.94M $23.59M
YoY Change
Total Liabilities & Shareholders Equity $23.38M $27.30M
YoY Change -53.29% -53.58%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$3.883M -$5.338M
YoY Change -52.27% -50.32%
Depreciation, Depletion And Amortization $6.000K $5.000K
YoY Change -97.16% -70.59%
Cash From Operating Activities -$3.651M -$4.100M
YoY Change -56.84% -47.76%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $6.000M
YoY Change -100.0% 94.11%
Cash From Investing Activities $0.00 $6.000M
YoY Change -100.0% 94.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -3.651M -4.100M
Cash From Investing Activities 0.000 6.000M
Cash From Financing Activities 0.000 0.000
Net Change In Cash -3.651M 1.900M
YoY Change 36410.0% -191.52%
FREE CASH FLOW
Cash From Operating Activities -$3.651M -$4.100M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001800315
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
CY2023Q4 glto Debt Securities Available For Sales Type Extensible List
DebtSecuritiesAvailableForSalesTypeExtensibleList
us-gaap:CorporateDebtSecuritiesMember
CY2024Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesAndOtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39655
dei Entity Registrant Name
EntityRegistrantName
GALECTO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1957007
dei Entity Address Address Line1
EntityAddressAddressLine1
75 State Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02109
dei City Area Code
CityAreaCode
+45
dei Local Phone Number
LocalPhoneNumber
70 70 52 10
dei Security12b Title
Security12bTitle
Common Stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
GLTO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27130196
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22862000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21465000
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11686000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2306000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3623000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
25168000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
36774000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1986000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1128000
CY2024Q2 us-gaap Assets
Assets
27297000
CY2023Q4 us-gaap Assets
Assets
38227000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
724000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1702000
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2985000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4128000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3709000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5830000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66000
CY2024Q2 us-gaap Liabilities
Liabilities
3709000
CY2023Q4 us-gaap Liabilities
Liabilities
5896000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27121030
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27121030
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27112697
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27112697
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
290291000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
288036000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266900000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256085000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
197000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
380000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23588000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
32331000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27297000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38227000
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1834000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8089000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4297000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18451000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2775000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3070000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6053000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6200000
CY2024Q2 us-gaap Restructuring Costs
RestructuringCosts
968000
us-gaap Restructuring Costs
RestructuringCosts
968000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
5577000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
11159000
us-gaap Operating Expenses
OperatingExpenses
11318000
us-gaap Operating Expenses
OperatingExpenses
24651000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5577000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11159000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11318000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24651000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
213000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
442000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
470000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
876000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
68000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
75000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
37000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
281000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
415000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
545000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
913000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5296000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10744000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10773000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23738000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-5338000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
us-gaap Net Income Loss
NetIncomeLoss
-10815000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27115536
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27115536
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26375076
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26375076
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27114116
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27114116
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26025929
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26025929
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-131000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-217000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10000
CY2024Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2000
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
25000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
34000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
117000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-129000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-183000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
107000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5467000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10754000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10998000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23631000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28159000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
891000
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-129000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-5338000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23588000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
50333000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1439000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2682000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
32331000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2250000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-183000
us-gaap Net Income Loss
NetIncomeLoss
-10815000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
23588000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
61753000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2873000
glto Stock Issued During Period Net Of Issuance Costs
StockIssuedDuringPeriodNetOfIssuanceCosts
200000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2705000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
107000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
43700000
us-gaap Profit Loss
ProfitLoss
-10815000
us-gaap Profit Loss
ProfitLoss
-23738000
us-gaap Depreciation
Depreciation
10000
us-gaap Depreciation
Depreciation
35000
us-gaap Share Based Compensation
ShareBasedCompensation
2250000
us-gaap Share Based Compensation
ShareBasedCompensation
2873000
glto Issuance Of Common Stock In Connection With Vesting Of Restricted Stock Units
IssuanceOfCommonStockInConnectionWithVestingOfRestrictedStockUnits
-5000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-70000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
248000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
165000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
199000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
6000
glto Accretion Of Lease Liability
AccretionOfLeaseLiability
30000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1317000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-450000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
857000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
203000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-978000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2207000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1038000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1639000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-171000
glto Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-227000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10036000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16983000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
21994000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11650000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
26459000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11650000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4465000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2705000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2705000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1614000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9813000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-217000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21465000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32786000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22862000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22956000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-266900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17000000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-5300000
us-gaap Profit Loss
ProfitLoss
-10800000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-10700000
us-gaap Profit Loss
ProfitLoss
-23700000
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
22900000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
25200000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3700000
CY2023Q4 us-gaap Investments And Cash
InvestmentsAndCash
33200000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
36800000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5800000
CY2023Q3 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
29
CY2023Q3 glto Work Force Reduction Precentage
WorkForceReductionPrecentage
0.70
CY2024Q2 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
8
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
4500000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
106000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
107000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
67000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000
CY2024Q2 us-gaap Depreciation
Depreciation
5000
us-gaap Depreciation
Depreciation
10000
CY2023Q2 us-gaap Depreciation
Depreciation
17000
us-gaap Depreciation
Depreciation
35000
CY2024Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12734000
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
25296000
CY2024Q2 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
1442000
CY2023Q4 glto Research And Development Tax Credit Receivable Current
ResearchAndDevelopmentTaxCreditReceivableCurrent
1438000
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
301000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
774000
CY2024Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
279000
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
280000
CY2024Q2 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
121000
CY2023Q4 glto Contract Research And Development Cost Current
ContractResearchAndDevelopmentCostCurrent
1046000
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
163000
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
85000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2306000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3623000
CY2024Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
200000
CY2023Q2 glto Operating Lease Rent Expense
OperatingLeaseRentExpense
100000
glto Operating Lease Rent Expense
OperatingLeaseRentExpense
300000
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
47000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
139000
us-gaap Operating Lease Cost
OperatingLeaseCost
143000
us-gaap Operating Lease Cost
OperatingLeaseCost
276000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
48000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
125000
us-gaap Operating Lease Payments
OperatingLeasePayments
140000
us-gaap Operating Lease Payments
OperatingLeasePayments
273000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
409000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
80000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
80000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
77000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1264000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
987000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
820000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1734000
CY2024Q2 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
118000
CY2023Q4 glto Contract Research And Development Costs Current
ContractResearchAndDevelopmentCostsCurrent
685000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
77000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
183000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
706000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
539000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2985000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4128000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6886889
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.58
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
108000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.49
glto Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1439703
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.22
glto Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5555186
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.59
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5270540
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y8M12D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4420549
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
891000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1439000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2250000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2873000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.042
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.993
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.910
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q2 glto Number Of Employees Reduced Due To Restructuring
NumberOfEmployeesReducedDueToRestructuring
8
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
0
CY2023 us-gaap Restructuring Charges
RestructuringCharges
3448000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
1593000
CY2023 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
121000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1734000
us-gaap Restructuring Charges
RestructuringCharges
968000
us-gaap Payments For Restructuring
PaymentsForRestructuring
1882000
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
820000
CY2023Q3 glto Employees Retention Bonus Payable
EmployeesRetentionBonusPayable
1200000
glto Employees Retention Bonus Amount
EmployeesRetentionBonusAmount
500000
CY2023 glto Employees Retention Bonus Amount
EmployeesRetentionBonusAmount
400000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-5338000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10744000
us-gaap Net Income Loss
NetIncomeLoss
-10815000
us-gaap Net Income Loss
NetIncomeLoss
-23738000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27115536
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27115536
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26375076
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26375076
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27114116
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27114116
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26025929
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26025929
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91

Files In Submission

Name View Source Status
0000950170-24-095383-index-headers.html Edgar Link pending
0000950170-24-095383-index.html Edgar Link pending
0000950170-24-095383.txt Edgar Link pending
0000950170-24-095383-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
glto-20240630.htm Edgar Link pending
glto-20240630.xsd Edgar Link pending
glto-ex10_1.htm Edgar Link pending
glto-ex10_2.htm Edgar Link pending
glto-ex31_1.htm Edgar Link pending
glto-ex31_2.htm Edgar Link pending
glto-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
glto-20240630_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable